"Molecule ChEMBL ID";"Molecule Name";"Molecule Max Phase";"Molecular Weight";"#RO5 Violations";"AlogP";"Compound Key";"Smiles";"Standard Type";"Standard Relation";"Standard Value";"Standard Units";"pChEMBL Value";"Data Validity Comment";"Comment";"Uo Units";"Ligand Efficiency BEI";"Ligand Efficiency LE";"Ligand Efficiency LLE";"Ligand Efficiency SEI";"Potential Duplicate";"Assay ChEMBL ID";"Assay Description";"Assay Type";"BAO Format ID";"BAO Label";"Assay Organism";"Assay Tissue ChEMBL ID";"Assay Tissue Name";"Assay Cell Type";"Assay Subcellular Fraction";"Assay Parameters";"Assay Variant Accession";"Assay Variant Mutation";"Target ChEMBL ID";"Target Name";"Target Organism";"Target Type";"Document ChEMBL ID";"Source ID";"Source Description";"Document Journal";"Document Year";"Cell ChEMBL ID";"Properties"
"CHEMBL4870304";"";"0";"499.53";"0";"3.51";"IV";"COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F";"Activity";"'='";"44.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4805722";"Inhibition of human QSK assessed as percent of control at 1000 nM by KINOMEscan assay relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4804283";"38";"Patent Bioactivity Data";"";"";"None";"Dose = 1000.0 nM"
"CHEMBL2348350";"";"0";"438.56";"0";"2.40";"15u";"CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1";"Activity";"'='";"97.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4806739";"Inhibition of human QSK assessed as percent of control at 2000 nM by KINOMEscan assay relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4804286";"38";"Patent Bioactivity Data";"";"";"None";"Dose = 2000.0 nM"
"CHEMBL105442";"CI-1040";"2";"478.66";"1";"5.04";"CI-1040";"O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908471";"Binding constant for QSK kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat. Biotechnol.";"2011";"None";""
"CHEMBL31965";"CANERTINIB";"3";"485.95";"0";"4.39";"CI-1033";"C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1";"Kd";"'='";"700.0";"nM";"6.16";"";"";"UO_0000065";"12.67";"0.25";"1.76";"6.95";"0";"CHEMBL1908471";"Binding constant for QSK kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat. Biotechnol.";"2011";"None";""
"CHEMBL24828";"VANDETANIB";"4";"475.36";"1";"5.00";"Vandetanib";"COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1";"Kd";"'='";"3900.0";"nM";"5.41";"";"";"UO_0000065";"11.38";"0.25";"0.41";"9.09";"0";"CHEMBL1908471";"Binding constant for QSK kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat. Biotechnol.";"2011";"None";""
"CHEMBL1163565";"";"0";"530.98";"1";"4.92";"5o";"CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1";"Inhibition";"'<'";"50.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1166834";"Inhibition of QSK at 1 uM";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1165965";"1";"Scientific Literature";"Bioorg. Med. Chem.";"2010";"None";""
"CHEMBL1163566";"";"0";"488.95";"0";"4.66";"5n";"FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21";"Inhibition";"'<'";"50.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1166834";"Inhibition of QSK at 1 uM";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1165965";"1";"Scientific Literature";"Bioorg. Med. Chem.";"2010";"None";""
"CHEMBL1908391";"MASITINIB";"3";"498.66";"1";"5.26";"AB-1010";"Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908471";"Binding constant for QSK kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat. Biotechnol.";"2011";"None";""
"CHEMBL477772";"PAZOPANIB";"4";"437.53";"0";"3.14";"Pazopanib";"Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908471";"Binding constant for QSK kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat. Biotechnol.";"2011";"None";""
"CHEMBL445813";"AT-7519";"2";"382.25";"0";"2.45";"AT-7519";"O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908471";"Binding constant for QSK kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat. Biotechnol.";"2011";"None";""
"CHEMBL300138";"ENZASTAURIN";"3";"515.62";"1";"4.93";"LY-317615";"Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908471";"Binding constant for QSK kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat. Biotechnol.";"2011";"None";""
"CHEMBL10";"SB-203580";"0";"377.44";"0";"4.68";"SB-203580";"C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1";"Kd";"'='";"3900.0";"nM";"5.41";"";"";"UO_0000065";"14.33";"0.27";"0.73";"9.22";"0";"CHEMBL1908471";"Binding constant for QSK kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat. Biotechnol.";"2011";"None";""
"CHEMBL2204495";"";"0";"399.43";"1";"5.11";"1, GSK2578215A";"O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1";"Activity";"'='";"101.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL2213184";"Inhibition of SIK3 assessed as residual activity at 10 uM";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2203081";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2012";"None";""
"CHEMBL1230020";"PLX-4720";"0";"413.83";"0";"3.88";"PLX-4720";"CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908471";"Binding constant for QSK kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat. Biotechnol.";"2011";"None";""
"CHEMBL535";"SUNITINIB";"4";"398.48";"0";"3.33";"SU-11248";"CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1244949";"Binding affinity to QSK";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1240346";"1";"Scientific Literature";"Blood";"2009";"None";""
"CHEMBL4878072";"";"0";"449.56";"0";"4.30";"Senexin C/6148/GJ-2331/2335";"CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1";"Activity";"'='";"55.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4805134";"Inhibition of human QSK assessed as percent of control at 2000 nM by KINOMEscan assay relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4804282";"38";"Patent Bioactivity Data";"";"";"None";"Dose = 2000.0 nM"
"CHEMBL607535";"MEISOINDIGO";"0";"276.30";"0";"2.53";"Meisoindigo";"CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21";"Activity";"'='";"100.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4806177";"Inhibition of DNA-tagged human QSK assessed as percent of control at 50000 nM by qPCR analysis relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4804284";"38";"Patent Bioactivity Data";"";"";"None";"Dose = 50000.0 nM"
"CHEMBL2325741";"CAPIVASERTIB";"3";"428.92";"0";"2.15";"AZD-5363";"NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL2323775";"MK-8033";"1";"471.54";"0";"3.16";"MK-8033";"Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL2220486";"LUCITANIB";"2";"443.50";"0";"4.42";"Lucitanib";"CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL1614707";"MUBRITINIB";"1";"468.48";"1";"6.06";"Mubritinib";"FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL288441";"BOSUTINIB";"4";"530.46";"2";"5.19";"Bosutinib";"COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl";"Kd";"'='";"160.0";"nM";"6.80";"";"Uncertain";"UO_0000065";"12.81";"0.26";"1.61";"8.20";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";"r = 0.95 None"
"CHEMBL2048872";"";"0";"379.49";"0";"3.61";"AZD-1208";"N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL2103830";"FOSTAMATINIB";"4";"580.47";"2";"3.09";"Fostamatinib";"COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL189963";"PALBOCICLIB";"4";"447.54";"0";"2.97";"Palbociclib";"CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL1944698";"ZOTIRACICLIB";"1";"372.47";"0";"4.66";"SB-1317";"CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1";"Kd";"'='";"1300.0";"nM";"5.89";"";"Uncertain";"UO_0000065";"15.80";"0.29";"1.23";"11.71";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";"r = 0.97 None"
"CHEMBL1983111";"";"0";"474.49";"0";"4.06";"PF-03814735";"CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12";"Kd";"'='";"9648.0";"nM";"5.02";"";"Active";"UO_0000065";"10.57";"0.20";"0.96";"5.05";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";"r = 0.84 None"
"CHEMBL3545110";"RIBOCICLIB";"4";"434.55";"0";"2.80";"Ribociclib";"CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL215152";"AZD-1152-HQPA";"0";"507.57";"1";"3.50";"Barasertib_HQPA";"CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL587723";"AEE-788";"2";"440.60";"0";"4.94";"AEE-788";"CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL1908394";"GSK-461364";"1";"543.62";"2";"5.09";"GSK-461364";"C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL255863";"NILOTINIB";"4";"529.53";"2";"6.36";"Nilotinib";"Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL1721885";"SU-014813";"2";"442.49";"0";"1.69";"SU-14813";"Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL24828";"VANDETANIB";"4";"475.36";"1";"5.00";"Vandetanib";"COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL3545083";"RGB-286638";"1";"545.64";"1";"2.42";"RGB-286638";"COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL535";"SUNITINIB";"4";"398.48";"0";"3.33";"Sunitinib";"CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908471";"Binding constant for QSK kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat. Biotechnol.";"2011";"None";""
"CHEMBL4860979";"";"0";"466.54";"0";"3.21";"I-28";"CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1";"IC50";"'='";"30100.0";"nM";"4.52";"";"";"UO_0000065";"9.69";"0.19";"1.31";"4.29";"0";"CHEMBL4804482";"Inhibition of QSK in human NCI-H929 cells by mass spectroscopic analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"Blood";"NCI-H929";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4804281";"38";"Patent Bioactivity Data";"";"";"None";""
"CHEMBL4859660";"";"0";"378.36";"0";"3.33";"I-9";"Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O";"IC50";"'='";"72800.0";"nM";"4.14";"";"";"UO_0000065";"10.94";"0.20";"0.81";"3.72";"0";"CHEMBL4804482";"Inhibition of QSK in human NCI-H929 cells by mass spectroscopic analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"Blood";"NCI-H929";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4804281";"38";"Patent Bioactivity Data";"";"";"None";""
"CHEMBL509032";"TAE-684";"0";"614.22";"2";"5.02";"TAE-684";"COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1";"Kd";"'='";"1300.0";"nM";"5.89";"";"";"UO_0000065";"9.58";"0.19";"0.87";"5.72";"0";"CHEMBL1908471";"Binding constant for QSK kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat. Biotechnol.";"2011";"None";""
"CHEMBL4860979";"";"0";"466.54";"0";"3.21";"I-28";"CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1";"Inhibition";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4804664";"Inhibition of QSK in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"Blood";"NCI-H929";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4804281";"38";"Patent Bioactivity Data";"";"";"None";"Dose = 10.0 microM"
"CHEMBL608533";"MIDOSTAURIN";"4";"570.65";"2";"5.91";"Midostaurin";"CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4";"Kd";"'='";"98.0";"nM";"7.01";"";"";"UO_0000065";"12.28";"0.22";"1.10";"9.02";"1";"CHEMBL1244949";"Binding affinity to QSK";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1240346";"1";"Scientific Literature";"Blood";"2009";"None";""
"CHEMBL1240703";"CGP-52421";"0";"586.65";"2";"5.40";"CGP-52421";"CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O";"Kd";"'='";"230.0";"nM";"6.64";"";"";"UO_0000065";"11.32";"0.21";"1.24";"6.78";"0";"CHEMBL1244949";"Binding affinity to QSK";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1240346";"1";"Scientific Literature";"Blood";"2009";"None";""
"CHEMBL1171523";"";"0";"506.57";"2";"5.20";"3";"CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1";"Inhibition";"'='";"70.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1175244";"Inhibition of QSK at 10 uM";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1177794";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"None";""
"CHEMBL1908394";"GSK-461364";"1";"543.62";"2";"5.09";"GSK-461364A";"C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908471";"Binding constant for QSK kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat. Biotechnol.";"2011";"None";""
"CHEMBL608154";"";"0";"366.81";"0";"4.33";"MLN-120B";"COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908471";"Binding constant for QSK kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat. Biotechnol.";"2011";"None";""
"CHEMBL1908395";"";"0";"497.04";"0";"3.76";"JNJ-28312141";"CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908471";"Binding constant for QSK kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat. Biotechnol.";"2011";"None";""
"CHEMBL573339";"PI-103";"0";"348.36";"0";"2.98";"PI-103";"Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908471";"Binding constant for QSK kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat. Biotechnol.";"2011";"None";""
"CHEMBL4555884";"";"0";"484.09";"1";"5.19";"1";"COc1cc(Br)cc2[nH]cc(-c3oc(-c4ccc[nH]4)nc3I)c12";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4338192";"Inhibition of SIK3 (unknown origin) by [33P]-ATP filter binding kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4334516";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL2204495";"";"0";"399.43";"1";"5.11";"1, GSK2578215A";"O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1";"Activity";"'='";"85.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL2214641";"Inhibition of SIK3 assessed as residual activity at 1 uM";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2203081";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2012";"None";""
"CHEMBL3688339";"";"0";"487.43";"1";"6.04";"OTS-167";"CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1";"Kd";"'='";"356.0";"nM";"6.45";"";"Active";"UO_0000065";"13.23";"0.27";"0.41";"8.23";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";"r = 0.48 None"
"CHEMBL1801204";"AZD-8055";"1";"465.55";"0";"2.64";"AZD-8055";"COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL1614701";"SELUMETINIB";"4";"457.69";"0";"3.53";"Selumetinib";"Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL1233528";"VOLASERTIB";"3";"618.83";"1";"4.27";"Volasertib";"CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL592445";"GEDATOLISIB";"2";"615.74";"1";"3.02";"Gedatolisib";"CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL477772";"PAZOPANIB";"4";"437.53";"0";"3.14";"Pazopanib";"Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL2105759";"BARICITINIB";"4";"371.43";"0";"1.10";"Baricitinib";"CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL2408045";"SAPITINIB";"2";"473.94";"0";"3.76";"Sapitinib";"CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL607707";"PELITINIB";"2";"467.93";"1";"5.10";"Pelitinib";"CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL1241855";"RIGOSERTIB";"3";"451.50";"0";"2.80";"Rigosertib";"COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL2219422";"AFURESERTIB";"2";"427.33";"0";"3.89";"GSK-2110183";"Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL3039517";"RABUSERTIB";"2";"436.31";"0";"2.87";"Rabusertib";"Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL2103875";"TRAMETINIB";"4";"615.40";"1";"3.94";"Trametinib";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL1287853";"FEDRATINIB";"4";"524.69";"1";"4.82";"Fedratinib";"Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL1094408";"NMS-1286937";"0";"448.53";"0";"1.58";"NMS-1286937";"COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL565612";"SOTRASTAURIN";"2";"438.49";"0";"2.43";"Sotrastaurin";"CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL3218575";"PILARALISIB";"0";"448.53";"0";"4.49";"Pilaralisib-analogue";"Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL603469";"LESTAURTINIB";"3";"439.47";"0";"3.47";"Lestaurtinib";"C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O";"Kd";"'='";"848.0";"nM";"6.07";"";"Active";"UO_0000065";"13.82";"0.25";"2.60";"6.85";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";"r = 0.81 None"
"CHEMBL445813";"AT-7519";"2";"382.25";"0";"2.45";"AT-7519";"O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL2376648";"";"0";"547.42";"1";"4.28";"X-396";"C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL3544964";"RAVOXERTINIB";"1";"440.87";"0";"3.16";"GDC-0994";"Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL488436";"AZD-5438";"1";"371.47";"0";"3.38";"AZD-5438";"Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL2403108";"CERITINIB";"4";"558.15";"2";"6.36";"Ceritinib";"Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL3184679";"AZD-4547";"2";"463.58";"0";"3.65";"AZD-4547";"COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL1908397";"KW-2449";"1";"332.41";"0";"2.78";"KW-2449";"O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL221959";"TOFACITINIB";"4";"312.38";"0";"1.54";"Tofacitinib";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL377300";"BRIVANIB";"3";"370.38";"0";"3.52";"BMS-540215";"Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908471";"Binding constant for QSK kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat. Biotechnol.";"2011";"None";""
"CHEMBL1287853";"FEDRATINIB";"4";"524.69";"1";"4.82";"TG-101348";"Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1";"Kd";"'='";"1900.0";"nM";"5.72";"";"";"UO_0000065";"10.90";"0.21";"0.90";"5.27";"0";"CHEMBL1908471";"Binding constant for QSK kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat. Biotechnol.";"2011";"None";""
"CHEMBL2204495";"";"0";"399.43";"1";"5.11";"1, GSK2578215A";"O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1";"Activity";"'='";"100.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL2212019";"Inhibition of QSK assessed as residual activity at 10 uM relative to control";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2203081";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2012";"None";""
"CHEMBL566515";"";"0";"417.43";"0";"2.35";"66";"COc1ccccc1-n1c(-c2cc(O)ccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12";"Activity";"'='";"32.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1043883";"Binding affinity to QSK assessed as percentage of kinase remaining bound to the bead at 1 uM by T7 phage display based binding assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1154183";"1";"Scientific Literature";"J. Med. Chem.";"2009";"None";""
"CHEMBL4455512";"";"0";"315.31";"0";"2.99";"G3_9";"N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1";"Activity";"'='";"101.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4335289";"Inhibition of recombinant human SIK3 (1 to 307 residues) assessed as residual activity at 1 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4334438";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";""
"CHEMBL124660";"TANDUTINIB";"2";"562.72";"2";"5.03";"MLN-518";"COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1244949";"Binding affinity to QSK";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1240346";"1";"Scientific Literature";"Blood";"2009";"None";""
"CHEMBL576982";"QUIZARTINIB";"3";"560.68";"2";"5.86";"AC220";"CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1244949";"Binding affinity to QSK";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1240346";"1";"Scientific Literature";"Blood";"2009";"None";""
"CHEMBL2348350";"";"0";"438.56";"0";"2.40";"15u";"CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1";"Activity";"'='";"89.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4806739";"Inhibition of human QSK assessed as percent of control at 2000 nM by KINOMEscan assay relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4804286";"38";"Patent Bioactivity Data";"";"";"None";"Dose = 2000.0 nM"
"CHEMBL4859660";"";"0";"378.36";"0";"3.33";"I-9";"Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O";"Inhibition";"'='";"50.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4804664";"Inhibition of QSK in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"Blood";"NCI-H929";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4804281";"38";"Patent Bioactivity Data";"";"";"None";"Dose = 10.0 microM"
"CHEMBL255863";"NILOTINIB";"4";"529.53";"2";"6.36";"Nilotinib";"Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908471";"Binding constant for QSK kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat. Biotechnol.";"2011";"None";""
"CHEMBL1614701";"SELUMETINIB";"4";"457.69";"0";"3.53";"AZD-6244/ARRY-886";"Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908471";"Binding constant for QSK kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat. Biotechnol.";"2011";"None";""
"CHEMBL388978";"STAUROSPORINE";"0";"466.54";"0";"4.35";"Staurosporine";"CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4";"Kd";"'='";"0.46";"nM";"9.34";"";"";"UO_0000065";"20.01";"0.36";"4.99";"13.44";"0";"CHEMBL1908471";"Binding constant for QSK kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat. Biotechnol.";"2011";"None";""
"CHEMBL296468";"BMS-387032";"1";"380.54";"0";"3.66";"BMS-387032/SNS-032";"CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908471";"Binding constant for QSK kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat. Biotechnol.";"2011";"None";""
"CHEMBL180022";"NERATINIB";"4";"557.05";"2";"5.93";"HKI-272";"CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908471";"Binding constant for QSK kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat. Biotechnol.";"2011";"None";""
"CHEMBL3338802";"";"0";"439.91";"1";"5.70";"4j";"Cc1ccc(-c2cc(C(=O)Nc3ccnc(Cl)c3)nn2-c2ccc3ccccc3n2)cc1";"Activity";"'='";"81.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3388056";"Inhibition of SIK3 (unknown origin) assessed as remaining enzyme activity at 10 uM by radioactive [33P]-ATP filter binding assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351385";"1";"Scientific Literature";"Eur. J. Med. Chem.";"2014";"None";""
"CHEMBL4855542";"";"0";"372.45";"0";"3.89";"I-13";"Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O";"Inhibition";"'='";"35.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4804664";"Inhibition of QSK in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"Blood";"NCI-H929";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4804281";"38";"Patent Bioactivity Data";"";"";"None";"Dose = 10.0 microM"
"CHEMBL1289926";"AXITINIB";"4";"386.48";"0";"4.64";"Axitinib";"CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908471";"Binding constant for QSK kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat. Biotechnol.";"2011";"None";""
"CHEMBL101253";"VATALANIB";"3";"346.82";"1";"5.01";"PTK-787";"Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908471";"Binding constant for QSK kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat. Biotechnol.";"2011";"None";""
"CHEMBL525191";"";"0";"334.38";"0";"2.73";"GDC-0879";"OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908471";"Binding constant for QSK kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat. Biotechnol.";"2011";"None";""
"CHEMBL4281048";"";"0";"505.09";"1";"4.55";"40; JSH-150";"COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1";"Activity";"'='";"79.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4264510";"Binding affinity to wild-type human partial length QSK (A90 to L395 residues) expressed in mammalian expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261600";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";""
"CHEMBL601719";"CRIZOTINIB";"4";"450.35";"1";"5.04";"Crizotinib";"C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908471";"Binding constant for QSK kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat. Biotechnol.";"2011";"None";""
"CHEMBL522892";"DOVITINIB";"3";"392.44";"0";"2.54";"CHIR-258/TKI-258";"CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908471";"Binding constant for QSK kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat. Biotechnol.";"2011";"None";""
"CHEMBL2205766";"";"0";"346.42";"0";"1.45";"14, CZC24758";"CC(C)(C)NS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2211515";"Inhibition of KIAA0999";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2203257";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2012";"None";""
"CHEMBL1164180";"";"0";"502.97";"1";"5.00";"5e";"CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1";"Inhibition";"'<'";"50.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1166834";"Inhibition of QSK at 1 uM";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1165965";"1";"Scientific Literature";"Bioorg. Med. Chem.";"2010";"None";""
"CHEMBL261849";"GW632580X";"0";"366.42";"0";"2.83";"GW-2580";"COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908471";"Binding constant for QSK kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat. Biotechnol.";"2011";"None";""
"CHEMBL4080797";"";"0";"408.51";"0";"2.82";"35";"COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1";"Activity";"'='";"86.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4054983";"Inhibition of wild-type human partial length QSK (A90 to L395 residues) expressed in mammalian expression system assessed as residual activity at 50 nM by Kinomescan method relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052645";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL572881";"MOTESANIB";"3";"373.46";"0";"4.04";"AMG-706";"CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908471";"Binding constant for QSK kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat. Biotechnol.";"2011";"None";""
"CHEMBL1336";"SORAFENIB";"4";"464.83";"1";"5.55";"Sorafenib";"CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1244949";"Binding affinity to QSK";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1240346";"1";"Scientific Literature";"Blood";"2009";"None";""
"CHEMBL4436895";"";"0";"388.20";"0";"3.79";"46";"O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1";"Activity";"'='";"70.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4365936";"Inhibition of wild-type human partial length QSK (A90 to L395 residues) expressed in mammalian expression system assessed as residual activity at 10 uM by Kinomescan method relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4364269";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";""
"CHEMBL475251";"R-406";"2";"470.46";"0";"3.63";"R406";"COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908471";"Binding constant for QSK kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat. Biotechnol.";"2011";"None";""
"CHEMBL4473365";"";"0";"602.16";"1";"4.93";"7c";"C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C";"Activity";"'='";"61.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4382730";"Binding affinity to wild-type human partial length QSK (A90 to L395 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4382192";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";""
"CHEMBL4462318";"";"0";"616.66";"2";"5.27";"19i";"COc1cc2c(Oc3ccc(NS(=O)(=O)c4c(F)cccc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1";"Kd";"'='";"7630.0";"nM";"5.12";"";"";"UO_0000065";"8.30";"0.16";"-0.15";"5.49";"0";"CHEMBL4371460";"Binding affinity to QSK in SILAC-labeled human MDA-MB-231 cells lysate by mass spectrometry based kinAffinity assay";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"MDA-MB-231";"Lysate";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4371006";"1";"Scientific Literature";"J Med Chem";"2018";"CHEMBL3307960";""
"CHEMBL572878";"TOZASERTIB";"2";"464.60";"0";"3.50";"VX-680/MK-0457";"Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908471";"Binding constant for QSK kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat. Biotechnol.";"2011";"None";""
"CHEMBL4472294";"";"0";"390.45";"1";"5.13";"11g";"C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21";"Activity";"'='";"20.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4337114";"Inhibition of recombinant human SIK3 (1 to 307 residues) assessed as residual activity at 10 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4334471";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"None";""
"CHEMBL386051";"";"0";"443.36";"1";"5.77";"PD-173955";"CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1";"Kd";"'='";"99.0";"nM";"7.00";"";"";"UO_0000065";"15.80";"0.33";"1.23";"11.71";"0";"CHEMBL1908471";"Binding constant for QSK kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat. Biotechnol.";"2011";"None";""
"CHEMBL1421";"DASATINIB";"4";"488.02";"0";"3.31";"Dasatinib";"Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1";"Kd";"'='";"28.0";"nM";"7.55";"";"";"UO_0000065";"15.48";"0.31";"4.24";"7.09";"0";"CHEMBL1908471";"Binding constant for QSK kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat. Biotechnol.";"2011";"None";""
"CHEMBL494089";"GSK-690693";"1";"425.49";"0";"1.58";"GSK-690693";"CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908471";"Binding constant for QSK kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat. Biotechnol.";"2011";"None";""
"CHEMBL491473";"CEDIRANIB";"3";"450.51";"1";"5.22";"AZD-2171";"COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908471";"Binding constant for QSK kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat. Biotechnol.";"2011";"None";""
"CHEMBL249697";"BMS-345541";"0";"255.32";"0";"1.87";"BMS-345541";"Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908471";"Binding constant for QSK kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat. Biotechnol.";"2011";"None";""
"CHEMBL1164265";"";"0";"470.96";"0";"4.26";"5h";"CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1";"Inhibition";"'<'";"50.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1166834";"Inhibition of QSK at 1 uM";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1165965";"1";"Scientific Literature";"Bioorg. Med. Chem.";"2010";"None";""
"CHEMBL1908396";"";"0";"480.55";"1";"5.39";"Ki-20227";"COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908471";"Binding constant for QSK kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat. Biotechnol.";"2011";"None";""
"CHEMBL103667";"DORAMAPIMOD";"2";"527.67";"2";"5.99";"BIRB-796";"Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908471";"Binding constant for QSK kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat. Biotechnol.";"2011";"None";""
"CHEMBL1164181";"";"0";"469.42";"0";"4.63";"5g";"CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1";"Inhibition";"'<'";"50.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1166834";"Inhibition of QSK at 1 uM";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1165965";"1";"Scientific Literature";"Bioorg. Med. Chem.";"2010";"None";""
"CHEMBL1165499";"";"0";"436.51";"0";"3.61";"5d";"CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1";"Inhibition";"'<'";"50.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1166834";"Inhibition of QSK at 1 uM";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1165965";"1";"Scientific Literature";"Bioorg. Med. Chem.";"2010";"None";""
"CHEMBL259084";"MLN-8054";"1";"476.87";"1";"5.87";"MLN-8054";"O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908471";"Binding constant for QSK kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat. Biotechnol.";"2011";"None";""
"CHEMBL939";"GEFITINIB";"4";"446.91";"0";"4.28";"Gefitinib";"COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908471";"Binding constant for QSK kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat. Biotechnol.";"2011";"None";""
"CHEMBL1170139";"";"0";"545.61";"2";"5.68";"12";"CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1";"Inhibition";"'='";"77.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1175244";"Inhibition of QSK at 10 uM";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1177794";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"None";""
"CHEMBL1230609";"FORETINIB";"2";"632.66";"2";"5.77";"EXEL-2880/GSK-1363089";"COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908471";"Binding constant for QSK kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat. Biotechnol.";"2011";"None";""
"CHEMBL119385";"NEFLAMAPIMOD";"2";"436.27";"1";"5.49";"VX-745";"O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908471";"Binding constant for QSK kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat. Biotechnol.";"2011";"None";""
"CHEMBL1336";"SORAFENIB";"4";"464.83";"1";"5.55";"Sorafenib";"CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908471";"Binding constant for QSK kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat. Biotechnol.";"2011";"None";""
"CHEMBL554";"LAPATINIB";"4";"581.07";"2";"6.14";"Lapatinib";"CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908471";"Binding constant for QSK kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat. Biotechnol.";"2011";"None";""
"CHEMBL166031";"";"0";"352.39";"0";"4.80";"3";"CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1";"Inhibition";"'='";"9.52";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3631472";"Inhibition of SIK3 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3627608";"1";"Scientific Literature";"Bioorg. Med. Chem.";"2015";"None";""
"CHEMBL608533";"MIDOSTAURIN";"4";"570.65";"2";"5.91";"PKC-412";"CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4";"Kd";"'='";"98.0";"nM";"7.01";"";"";"UO_0000065";"12.28";"0.22";"1.10";"9.02";"0";"CHEMBL1908471";"Binding constant for QSK kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat. Biotechnol.";"2011";"None";""
"CHEMBL4515441";"";"0";"597.12";"2";"6.05";"15a";"C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl";"Activity";"'='";"69.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4358099";"Binding affinity to wild-type human partial length QSK (A90 to L395 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354843";"1";"Scientific Literature";"J Med Chem";"2020";"None";""
"CHEMBL521851";"PICTILISIB";"2";"513.65";"1";"2.15";"GDC-0941";"CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908471";"Binding constant for QSK kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat. Biotechnol.";"2011";"None";""
"CHEMBL4576489";"";"0";"915.85";"None";"None";"8b";"CO[C@@H]1[C@H](N(C)CCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4";"Kd";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4322746";"Binding affinity to recombinant N-terminal His-FLAG-GST-tagged SIK3 (unknown origin) (59 to 365 residues) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321812";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308860";""
"CHEMBL941";"IMATINIB";"4";"493.62";"0";"4.59";"Imatinib";"Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908471";"Binding constant for QSK kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat. Biotechnol.";"2011";"None";""
"CHEMBL4855542";"";"0";"372.45";"0";"3.89";"I-13";"Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O";"IC50";"'='";"47800.0";"nM";"4.32";"";"";"UO_0000065";"11.60";"0.22";"0.43";"5.34";"0";"CHEMBL4804482";"Inhibition of QSK in human NCI-H929 cells by mass spectroscopic analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"Blood";"NCI-H929";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4804281";"38";"Patent Bioactivity Data";"";"";"None";""
"CHEMBL1950289";"TANZISERTIB";"2";"448.45";"0";"3.66";"Tanzisertib";"O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1";"Kd";"'='";"2981.0";"nM";"5.53";"";"Active";"UO_0000065";"12.32";"0.24";"1.87";"5.69";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";"r = 0.87 None"
"CHEMBL3813873";"PEXIDARTINIB";"4";"417.82";"1";"5.23";"Pexidartinib";"FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL2001019";"PF-04217903";"1";"372.39";"0";"1.67";"PF-04217903";"OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL274654";"ORANTINIB";"3";"310.35";"0";"3.14";"Orantinib";"Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL3353410";"OSIMERTINIB";"4";"499.62";"0";"4.51";"Osimertinib";"C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL3991934";"";"0";"591.54";"1";"4.90";"ACTB-1003";"COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL230011";"TG100-115";"2";"346.35";"0";"2.33";"TG-100115";"Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL575448";"BMS-754807";"2";"461.51";"0";"3.61";"BMS-754807";"C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL3264002";"";"0";"471.47";"0";"2.68";"Ro-5126766";"CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL2138625";"";"0";"507.01";"1";"4.67";"AV-412";"C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL124660";"TANDUTINIB";"2";"562.72";"2";"5.03";"MLN-518";"COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908471";"Binding constant for QSK kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat. Biotechnol.";"2011";"None";""
"CHEMBL576982";"QUIZARTINIB";"3";"560.68";"2";"5.86";"AC220";"CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908471";"Binding constant for QSK kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat. Biotechnol.";"2011";"None";""
"CHEMBL384304";"RG-547";"2";"441.46";"0";"1.41";"R547";"COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908471";"Binding constant for QSK kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat. Biotechnol.";"2011";"None";""
"CHEMBL223360";"LINIFANIB";"3";"375.41";"0";"4.90";"ABT-869";"Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908471";"Binding constant for QSK kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat. Biotechnol.";"2011";"None";""
"CHEMBL553";"ERLOTINIB";"4";"393.44";"0";"3.41";"Erlotinib";"C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908471";"Binding constant for QSK kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat. Biotechnol.";"2011";"None";""
"CHEMBL1077604";"ROHITUKINE";"0";"305.33";"0";"1.29";"1";"Cc1cc(=O)c2c(O)cc(O)c([C@H]3CCN(C)C[C@H]3O)c2o1";"Activity";"'='";"28.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3829284";"Inhibition of human SIK3 (2 to 1369 residues) assessed as remaining enzyme activity at 50 uM after 30 mins by 33P-ATP filter-binding assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3826966";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2016";"None";""
"CHEMBL3969370";"";"0";"533.59";"2";"5.26";"1; FMF-01-086-2";"C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1";"Activity";"'='";"88.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4186021";"Binding affinity to wild-type human partial length QSK (A90 to L395 residues) expressed in HEK293 cells at 1 uM by Kinomescan method relative to control";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4184148";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL1241674";"";"0";"308.35";"0";"2.84";"PP-242";"CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21";"Kd";"'='";"2900.0";"nM";"5.54";"";"";"UO_0000065";"17.96";"0.33";"2.70";"5.24";"0";"CHEMBL1908471";"Binding constant for QSK kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat. Biotechnol.";"2011";"None";""
"CHEMBL4077554";"";"0";"1215.15";"None";"None";"ARC-1424-5O";"NCCCC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CCCCCCCCOc1nc2cc(C(=O)O)ccc2c2cnccc12)C(=O)O";"Activity";"'='";"90.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4050365";"Inhibition of human SIK3 assessed as residual activity at 1 uM in presence of [33P]ATP by filter binding assay relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4049403";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";""
"CHEMBL574738";"AST-487";"1";"529.57";"2";"5.11";"AST-487";"CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908471";"Binding constant for QSK kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat. Biotechnol.";"2011";"None";""
"CHEMBL502835";"NINTEDANIB";"4";"539.64";"1";"3.62";"BIBF-1120";"COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908471";"Binding constant for QSK kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat. Biotechnol.";"2011";"None";""
"CHEMBL4438748";"";"0";"457.49";"0";"4.13";"12j";"CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4379438";"Inhibition of recombinant human SIK3 (1 to 307 residues) using KKKVSRSGLYRSP as substrate incubated for 40 mins in presence of [gamma33P]ATP by radiometric scintillation counting analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376834";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL464552";"";"0";"532.58";"1";"3.40";"GSK-1838705A";"CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908471";"Binding constant for QSK kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat. Biotechnol.";"2011";"None";""
"CHEMBL428690";"ALVOCIDIB";"3";"401.85";"0";"3.30";"Alvocidib";"CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL2105717";"CABOZANTINIB";"4";"501.51";"2";"5.54";"Cabozantinib";"COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL1230609";"FORETINIB";"2";"632.66";"2";"5.77";"Foretinib";"COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL377300";"BRIVANIB";"3";"370.38";"0";"3.52";"Brivanib";"Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL101253";"VATALANIB";"3";"346.82";"1";"5.01";"Vatalanib";"Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL217092";"SARACATINIB";"3";"542.04";"1";"3.94";"Saracatinib";"CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1";"Kd";"'='";"4851.0";"nM";"5.31";"";"Active";"UO_0000065";"9.80";"0.19";"1.37";"5.88";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";"r = 0.92 None"
"CHEMBL1078178";"MOMELOTINIB";"3";"414.47";"0";"2.98";"Momelotinib";"N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1";"Kd";"'='";"859.0";"nM";"6.07";"";"Active";"UO_0000065";"14.64";"0.27";"3.09";"5.88";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";"r = 0.55 None"
"CHEMBL3301612";"ENCORAFENIB";"4";"540.02";"1";"3.91";"Encorafenib";"COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL2103842";"VARLITINIB";"2";"466.95";"1";"5.25";"Varlitinib";"C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL3699142";"";"0";"464.57";"0";"4.17";"BI-847325";"CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL2140408";"AMG-900";"1";"503.59";"2";"6.64";"AMG-900";"Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL254760";"MGCD-265";"0";"517.61";"2";"5.68";"MGCD-265";"Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL482967";"CYC-116";"1";"368.47";"0";"3.07";"Cyc-116";"Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1";"Kd";"'='";"10318.0";"nM";"4.99";"";"Active";"UO_0000065";"13.53";"0.26";"1.92";"5.59";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";"r = 0.76 None"
"CHEMBL2103882";"TIVANTINIB";"3";"369.42";"0";"3.59";"Tivantinib";"O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL3745885";"";"0";"467.46";"0";"3.66";"7ao; ON1231320";"Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3750158";"Inhibition of human SIK3 using [AMARAASAAALARRR] as substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745707";"1";"Scientific Literature";"Bioorg. Med. Chem.";"2016";"None";""
"CHEMBL230011";"TG100-115";"2";"346.35";"0";"2.33";"TG-100-115";"Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908471";"Binding constant for QSK kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat. Biotechnol.";"2011";"None";""
"CHEMBL4209540";"";"0";"318.41";"0";"4.31";"4b";"Cc1cccc(-c2nc(N)sc2-c2ccc3ncccc3n2)c1";"Activity";"'='";"86.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4178157";"Inhibition of human SIK3 (2 to 1369 residues) assessed as residual activity at 500 nM in presence of 33P-ATP by filter binding assay relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177526";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";""
"CHEMBL4564973";"";"0";"544.64";"1";"4.20";"50";"O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1";"Inhibition";"'='";"93.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4389926";"Inhibition of wild-type human partial length QSK (A90 to L395 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4387741";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"None";""
"CHEMBL3137336";"UPROSERTIB";"2";"429.25";"0";"3.56";"Uprosertib";"Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL1983268";"ENTRECTINIB";"4";"560.65";"2";"5.03";"Entrectinib";"CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL558752";"RAF-265";"2";"518.42";"2";"6.93";"RAF-265";"Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL4207014";"";"0";"405.44";"0";"2.34";"19";"CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1";"Inhibition";"'='";"20.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4191193";"Inhibition of recombinant human SIK3 (1 to 307 residues) at 1 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4190187";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL1922094";"APITOLISIB";"2";"498.61";"1";"0.90";"Apitolisib";"Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL572878";"TOZASERTIB";"2";"464.60";"0";"3.50";"Tozasertib";"Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL1908360";"EVEROLIMUS";"4";"958.24";"3";"6.20";"Certican";"CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL1908391";"MASITINIB";"3";"498.66";"1";"5.26";"Masitinib";"Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL411907";"SONOLISIB";"2";"525.60";"1";"3.13";"Sonolisib";"C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C";"Kd";"'='";"11.0";"nM";"7.96";"";"Uncertain";"UO_0000065";"15.14";"0.29";"4.83";"6.66";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";"r = 0.99 None"
"CHEMBL3334567";"SAVOLITINIB";"3";"345.37";"0";"1.88";"Volitinib";"C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL1173655";"AFATINIB";"4";"485.95";"0";"4.39";"BIBW-2992";"CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908471";"Binding constant for QSK kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat. Biotechnol.";"2011";"None";""
"CHEMBL2396661";"ALPELISIB";"4";"441.48";"0";"3.84";"BYL-719";"Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL482968";"ENMD-2076";"2";"375.48";"0";"3.17";"ENMD-2076";"Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL564829";"MILCICLIB";"2";"460.59";"0";"2.57";"Milciclib";"CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2";"Kd";"'='";"266.0";"nM";"6.58";"";"Active";"UO_0000065";"14.28";"0.26";"4.01";"7.21";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";"r = 0.93 None"
"CHEMBL223360";"LINIFANIB";"3";"375.41";"0";"4.90";"Linifanib";"Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL2103851";"AMUVATINIB";"2";"447.52";"0";"3.30";"Amuvatinib";"S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL460702";"BMS-777607";"2";"512.90";"2";"5.19";"BMS-777607";"CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL1667969";"SAR-407899";"2";"244.29";"0";"1.66";"SAR-407899";"O=c1[nH]ccc2cc(OC3CCNCC3)ccc12";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL598797";"CUDC-101";"1";"434.50";"0";"4.20";"CUDC-101";"C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL3337894";"T-26c";"0";"479.51";"0";"3.34";"EUB0000729";"COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1";"% Control";"";"63.5";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507300";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL180022";"NERATINIB";"4";"557.05";"2";"5.93";"Neratinib";"CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL3544932";"TAK-901";"1";"504.66";"1";"4.62";"TAK-901";"CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL402548";"DANUSERTIB";"2";"474.57";"0";"2.64";"Danusertib";"CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL3187723";"BINIMETINIB";"4";"441.23";"0";"3.01";"Binimetinib";"Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL3545366";"VOXTALISIB";"2";"270.30";"0";"1.09";"XL-765";"CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL601719";"CRIZOTINIB";"4";"450.35";"1";"5.04";"Crizotinib";"C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL388978";"STAUROSPORINE";"0";"466.54";"0";"4.35";"STS";"CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4";"IC50";"'='";"1.24";"nM";"8.91";"";"";"UO_0000065";"19.09";"0.35";"4.56";"12.82";"0";"CHEMBL4328605";"Inhibition of human SIK3 using AMARAASAAALARRR as substrate by [gamma-33P]-ATP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4325871";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";""
"CHEMBL388978";"STAUROSPORINE";"0";"466.54";"0";"4.35";"STS";"CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4";"Activity";"'<'";"65.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4328241";"Inhibition of human SIK3 assessed as residual activity at 100 uM using AMARAASAAALARRR as substrate by [gamma-33P]-ATP assay relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4325871";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";""
"CHEMBL4526341";"A-108";"0";"504.47";"2";"5.04";"EUB0000736";"Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1";"% Control";"";"97.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507257";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL4586794";"ABT-100";"0";"504.47";"2";"5.04";"EUB0000289";"Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1";"% Control";"";"67.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507257";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL4538591";"BAY-440";"0";"574.01";"1";"4.47";"EUB0000701";"CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl";"% Control";"";"83.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507318";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL4174988";"";"0";"494.04";"0";"4.20";"15i";"Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1";"Activity";"'='";"100.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4157242";"Binding affinity to wild-type human partial length QSK (A90 to L395 residues) expressed in mammalian expression system assessed as residual binding at 1 uM by Kinomescan method relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4152344";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";""
"CHEMBL4533018";"";"0";"404.94";"0";"2.21";"IM-93";"CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl";"Activity";"'='";"93.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4308019";"Binding affinity to wild-type human partial length QSK (A90 to L395 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304811";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";""
"CHEMBL1421";"DASATINIB";"4";"488.02";"0";"3.31";"Dasatinib";"Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1";"Kd";"'='";"147.0";"nM";"6.83";"";"Active";"UO_0000065";"14.00";"0.28";"3.52";"6.42";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";"r = 0.9 None"
"CHEMBL1873475";"IBRUTINIB";"4";"440.51";"0";"4.22";"Ibrutinib";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL1088751";"PH-797804";"2";"477.31";"0";"4.43";"PH-797804";"CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL403989";"TG100-801";"2";"580.09";"2";"7.09";"TG-100801";"Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL4539943";"BAY-694";"0";"505.57";"1";"3.60";"EUB0000725";"O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O";"% Control";"";"84.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507264";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL1834199";"BI 99990";"0";"391.47";"0";"4.15";"EUB0000738";"CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1";"% Control";"";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507280";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL2386889";"SCH-900776";"2";"376.26";"0";"1.94";"SCH-900776";"Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL1289601";"LENVATINIB";"4";"426.86";"0";"4.07";"Lenvatinib";"COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL1614710";"OSI-930";"1";"443.45";"1";"6.06";"OSI-930";"O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL3182444";"MK-5108";"1";"461.95";"1";"5.71";"MK-5108";"O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL1236107";"SGX-523";"1";"359.42";"0";"3.22";"SGX-523";"Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL1289494";"TIVOZANIB";"4";"454.87";"1";"5.64";"Tivozanib";"COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL576982";"QUIZARTINIB";"3";"560.68";"2";"5.86";"Quizartinib";"CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL553";"ERLOTINIB";"4";"393.44";"0";"3.41";"Erlotinib";"C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL3408248";"";"0";"457.48";"0";"3.78";"AZD-8186";"C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL1230165";"SILMITASERTIB";"2";"349.78";"0";"4.88";"Silmitasertib";"O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL281948";"K-252A";"0";"467.48";"0";"3.66";"K-252a";"COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4";"Kd";"'='";"4027.0";"nM";"5.39";"";"Active";"UO_0000065";"11.54";"0.21";"1.74";"5.70";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";"r = 0.96 None"
"CHEMBL1738797";"ALECTINIB";"4";"482.63";"0";"4.77";"Alectinib";"CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL3545137";"PF-00477736";"1";"419.49";"0";"1.99";"PF-477736";"Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1";"Kd";"'='";"386.0";"nM";"6.41";"";"Active";"UO_0000065";"15.29";"0.28";"4.42";"5.07";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";"r = 0.96 None"
"CHEMBL571948";"Y-39983";"1";"280.33";"0";"2.83";"Y-39983";"C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1";"Kd";"'='";"71.0";"nM";"7.15";"";"Active";"UO_0000065";"25.50";"0.46";"4.32";"8.53";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";"r = 0.95 None"
"CHEMBL1229517";"VEMURAFENIB";"4";"489.93";"1";"5.54";"Vemurafenib";"CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL941";"IMATINIB";"4";"493.62";"0";"4.59";"Imatinib";"Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL3301607";"FILGOTINIB";"4";"425.51";"0";"1.98";"Filgotinib";"O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL14762";"SELICICLIB";"2";"354.46";"0";"3.20";"Seliciclib";"CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL415049";"BARASERTIB";"3";"587.55";"1";"3.62";"Barasertib";"CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL288441";"BOSUTINIB";"4";"530.46";"2";"5.19";"SKI-606";"COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl";"Kd";"'='";"64.0";"nM";"7.19";"";"";"UO_0000065";"13.56";"0.27";"2.00";"8.68";"0";"CHEMBL1908471";"Binding constant for QSK kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat. Biotechnol.";"2011";"None";""
"CHEMBL491473";"CEDIRANIB";"3";"450.51";"1";"5.22";"Cediranib";"COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL2017974";"BUPARLISIB";"3";"410.40";"0";"1.81";"Buparlisib";"Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL3545360";"ASP-3026";"1";"580.76";"2";"3.77";"ASP-3026";"COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL4084193";"";"0";"None";"None";"None";"RDEA-436";"";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL3544944";"BMS-863233";"2";"289.72";"0";"2.75";"XL-413";"O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL1789941";"RUXOLITINIB";"4";"306.37";"0";"3.47";"2, INCB018424";"N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL1084546";"PF-00562271";"1";"507.50";"1";"3.14";"PF-562271";"CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL1789941";"RUXOLITINIB";"4";"306.37";"0";"3.47";"INCB18424";"N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1";"Kd";"'='";"1300.0";"nM";"5.89";"";"";"UO_0000065";"19.21";"0.35";"2.42";"7.08";"0";"CHEMBL1908471";"Binding constant for QSK kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat. Biotechnol.";"2011";"None";""
"CHEMBL4564337";"";"0";"358.20";"0";"4.59";"3";"COc1cc2c(-c3cnc(-c4ccc[nH]4)o3)c[nH]c2cc1Br";"Activity";"'='";"94.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4338228";"Binding affinity to wild-type human partial length SIK3 (A90 to L395 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by active-site directed competition binding assay based Kinomescan method relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4334516";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL3907479";"FGFR INHIBITOR DEBIO 1347";"2";"356.39";"0";"3.35";"CH-5183284";"Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL4557538";"";"0";"372.86";"0";"3.51";"3c; SKLB0533";"Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1";"Activity";"'='";"119.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4314529";"Inhibition of human SIK3 (1 to 307 residues) using KKKVSRSGLYRSPSMPENLNRPR as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4311992";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";""
"CHEMBL603469";"LESTAURTINIB";"3";"439.47";"0";"3.47";"CEP-701";"C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O";"Kd";"'='";"120.0";"nM";"6.92";"";"";"UO_0000065";"15.75";"0.29";"3.45";"7.81";"1";"CHEMBL1244949";"Binding affinity to QSK";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1240346";"1";"Scientific Literature";"Blood";"2009";"None";""
"CHEMBL3991927";"";"0";"424.48";"0";"3.24";"HMN-214";"COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL3545307";"MERESTINIB";"2";"552.54";"2";"5.75";"LY-2801653";"Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL4636120";"";"0";"407.49";"0";"4.29";"11b; M4K2163";"COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)cc(OC)c1F";"Inhibition";"'='";"51.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4626177";"Inhibition of SIK3 (unknown origin) at 1 uM relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622974";"1";"Scientific Literature";"J Med Chem";"2020";"None";""
"CHEMBL3971067";"";"0";"378.48";"0";"3.00";"45";"CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1";"Inhibition";"'='";"-27.5";"%";"";"Outside typical range";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4046057";"Inhibition of QSK conserved Lys1 (VAIKIIDKTQLDEENLKK) in human PBMC at 0.1 uM";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043168";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL1822054";"";"0";"460.88";"0";"3.34";"10";"CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1";"Activity";"'='";"100.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1826694";"Activity of QSK kinase at 1 uM";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821651";"1";"Scientific Literature";"J. Med. Chem.";"2011";"None";""
"CHEMBL4855726";"";"0";"504.02";"2";"2.53";"B3";"Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1";"Activity";"'<'";"25.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4808003";"Inhibition of SIK3 (unknown origin) assessed as residual activity measured at 1 uM";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4806967";"38";"Patent Bioactivity Data";"";"";"None";"Dose = 1.0 microM"
"CHEMBL4578164";"MRL-CB1-NC";"0";"550.85";"2";"5.80";"EUB0000316";"CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O";"% Control";"";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507287";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL3991935";"";"0";"438.31";"0";"3.30";"P-276-00";"CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL536151";"";"0";"383.68";"1";"5.34";"IMD-0354";"O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL2041933";"AZD-7762";"1";"362.43";"0";"2.53";"AZD-7762";"NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1";"Kd";"'='";"43.0";"nM";"7.37";"";"Active";"UO_0000065";"20.33";"0.40";"4.84";"7.65";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";"r = 0.99 None"
"CHEMBL3218578";"BGT-226";"2";"534.54";"1";"4.38";"BGT-226";"COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL1614725";"TAK-285";"1";"547.97";"2";"5.92";"TAK-285";"CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL2146883";"COBIMETINIB";"4";"531.32";"1";"3.78";"Cobimetinib";"O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL3545085";"XL-228";"1";"437.55";"0";"3.30";"XL-228";"CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL603469";"LESTAURTINIB";"3";"439.47";"0";"3.47";"CEP-701";"C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O";"Kd";"'='";"120.0";"nM";"6.92";"";"";"UO_0000065";"15.75";"0.29";"3.45";"7.81";"0";"CHEMBL1908471";"Binding constant for QSK kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat. Biotechnol.";"2011";"None";""
"CHEMBL450786";"PHA-665752";"0";"641.62";"2";"6.11";"PHA-665752";"Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908471";"Binding constant for QSK kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat. Biotechnol.";"2011";"None";""
"CHEMBL221959";"TOFACITINIB";"4";"312.38";"0";"1.54";"CP-690550";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908471";"Binding constant for QSK kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat. Biotechnol.";"2011";"None";""
"CHEMBL1421";"DASATINIB";"4";"488.02";"0";"3.31";"A8";"Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"17.01";"0.34";"4.99";"7.79";"0";"CHEMBL4807589";"Inhibition of SIK3 (unknown origin) using RBER-CHKtide as substrate in presence of [32P]gammaATP by microplate scintillation counter analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4806967";"38";"Patent Bioactivity Data";"";"";"None";""
"CHEMBL3971067";"";"0";"378.48";"0";"3.00";"45";"CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1";"Inhibition";"'='";"4.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4045816";"Inhibition of QSK conserved Lys1 (VAIKIIDKTQLDEENLKK) in human PBMC at 1 uM";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043168";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL4749141";"";"0";"367.48";"0";"3.23";"44";"Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1";"Activity";"'='";"30.3";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4674198";"Inhibition of human SIK3 using AMARAASAAALARRR as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673210";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"Dose = 1.0 microM"
"CHEMBL4536197";"A-486";"0";"536.48";"1";"3.68";"EUB0000326";"CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O";"% Control";"";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507259";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL3137331";"DEFACTINIB";"2";"510.50";"1";"2.40";"EUB0000138";"CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1";"% Control";"";"82.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507299";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 100.0 nM"
"CHEMBL379218";"";"0";"358.45";"0";"3.88";"A-674563";"Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908471";"Binding constant for QSK kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat. Biotechnol.";"2011";"None";""
"CHEMBL2105728";"CRENOLANIB";"3";"443.55";"0";"3.92";"Crenolanib";"CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1";"Kd";"'='";"2.0";"nM";"8.70";"";"Active";"UO_0000065";"19.61";"0.36";"4.78";"11.09";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";"r = 0.96 None"
"CHEMBL259084";"MLN-8054";"1";"476.87";"1";"5.87";"MLN-8054";"O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL513909";"BI-2536";"2";"521.67";"1";"3.56";"BI-2536";"CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL939";"GEFITINIB";"4";"446.91";"0";"4.28";"Gefitinib";"COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL1079175";"MK-2206";"2";"407.48";"0";"4.24";"MK-2206";"NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL2165191";"AZD-6482";"1";"408.46";"0";"2.71";"AZD-6482";"Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL2029988";"CEP-32496";"1";"517.46";"2";"5.91";"CEP-32496";"COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL2087361";"ICOTINIB";"3";"391.43";"0";"3.16";"Icotinib";"C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL2035187";"PACRITINIB";"3";"472.59";"0";"4.96";"Pacritinib";"C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL3301622";"GILTERITINIB";"4";"552.72";"1";"2.70";"Gilteritinib";"CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL91829";"RUBOXISTAURIN";"3";"468.56";"0";"3.51";"Ruboxistaurin";"CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL1236682";"REFAMETINIB";"2";"572.34";"1";"3.48";"Refametinib";"COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL1971943";"BAY-549";"0";"402.79";"0";"4.71";"EUB0000716";"Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12";"% Control";"";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507274";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 100.0 nM"
"CHEMBL571546";"TIRBANIBULIN";"4";"431.54";"0";"3.32";"KX2-391";"O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL4785602";"";"0";"358.51";"0";"3.97";"46";"Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1";"Activity";"'='";"94.87";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4674198";"Inhibition of human SIK3 using AMARAASAAALARRR as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673210";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"Dose = 1.0 microM"
"CHEMBL4446405";"";"0";"292.81";"0";"1.21";"7b; ASR352";"C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]";"Activity";"'='";"100.77";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4327877";"Inhibition of human SIK3 assessed as residual activity at 1 uM using AMARAASAAALARRR as substrate by [gamma-33P]-ATP assay relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4325871";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";""
"CHEMBL413";"SIROLIMUS";"4";"914.19";"3";"6.18";"Rapamycin";"CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL1090479";"GSK-1070916";"1";"507.64";"2";"5.94";"GSK-1070916";"CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL1233300";"HYDROXYFASUDIL";"0";"307.38";"0";"0.92";"Hydroxyfasudil";"O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL3039525";"GOLVATINIB";"2";"633.70";"1";"4.75";"Golvatinib";"CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL483321";"CP-724714";"2";"469.55";"0";"4.95";"CP-724714";"COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL3109738";"";"0";"457.37";"1";"5.14";"JNJ-26483327";"COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL1173655";"AFATINIB";"4";"485.95";"0";"4.39";"Afatinib";"CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL514201";"TALMAPIMOD";"2";"513.01";"1";"3.98";"Talmapimod";"C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL253969";"OSI-632";"2";"532.41";"1";"3.86";"CP-547632";"NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1";"Kd";"'='";"1564.0";"nM";"5.81";"";"Active";"UO_0000065";"10.90";"0.25";"1.95";"5.30";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";"r = 0.96 None"
"CHEMBL3545308";"ROCILETINIB";"3";"555.56";"1";"4.78";"Rociletinib";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL1952329";"SGI-1776";"1";"405.42";"0";"4.05";"SGI-1776";"CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL4568120";"";"0";"388.83";"0";"3.29";"G28_14";"C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl";"Activity";"'='";"96.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4335289";"Inhibition of recombinant human SIK3 (1 to 307 residues) assessed as residual activity at 1 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4334438";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";""
"CHEMBL4476426";"";"0";"437.09";"1";"5.35";"5";"COc1cc(Br)cc2[nH]cc(-c3cnc(-c4cc(Br)c[nH]4)o3)c12";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4338192";"Inhibition of SIK3 (unknown origin) by [33P]-ATP filter binding kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4334516";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL1236107";"SGX-523";"1";"359.42";"0";"3.22";"SGX-523";"Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908471";"Binding constant for QSK kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat. Biotechnol.";"2011";"None";""
"CHEMBL4445670";"BAY-885";"0";"515.54";"1";"3.28";"EUB0000250";"CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1";"% residual kinase activity";"";"96.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4881236";"SIK3(h) Eurofins Kinase panel";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507268";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1.0 µM"
"CHEMBL4557026";"ERKi-NC";"0";"312.33";"0";"1.73";"EUB0000700";"C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1";"% Control";"";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507286";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL4530401";"MRL-SYKi-NC";"0";"505.56";"2";"6.37";"EUB0000704";"Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1";"% Control";"";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507285";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 100.0 nM"
"CHEMBL4097778";"TP-030n";"0";"458.54";"0";"1.13";"TP-030n";"CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21";"IC50";"";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4885434";"QSK(SIK3LGP1) Takeda global kinase panel";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507327";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1.0 µM"
"CHEMBL1721885";"SU-014813";"2";"442.49";"0";"1.69";"SU-14813";"Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908471";"Binding constant for QSK kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat. Biotechnol.";"2011";"None";""
"CHEMBL1908397";"KW-2449";"1";"332.41";"0";"2.78";"KW-2449";"O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1";"Kd";"'='";"2300.0";"nM";"5.64";"";"";"UO_0000065";"16.96";"0.31";"2.86";"9.24";"0";"CHEMBL1908471";"Binding constant for QSK kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat. Biotechnol.";"2011";"None";""
"CHEMBL3577885";"PF-05105679";"1";"428.46";"1";"5.48";"EUB0000304";"C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1";"% Control";"";"80.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507296";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL1088752";"LOSMAPIMOD";"3";"383.47";"0";"3.86";"Losmapimod";"Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL3545328";"XL-019";"1";"444.54";"0";"3.41";"XL-019";"O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1";"Kd";"'='";"206.0";"nM";"6.69";"";"Active";"UO_0000065";"15.04";"0.28";"3.28";"7.31";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";"r = 0.81 None"
"CHEMBL4878274";"";"0";"468.59";"0";"2.36";"C1";"Cc1nc(Nc2ncc(C(=O)Nc3c(C)ccnc3C)s2)cc(N2CCN(CCO)CC2)n1";"IC50";"'='";"867.0";"nM";"6.06";"";"";"UO_0000065";"12.94";"0.25";"3.70";"5.08";"0";"CHEMBL4807589";"Inhibition of SIK3 (unknown origin) using RBER-CHKtide as substrate in presence of [32P]gammaATP by microplate scintillation counter analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4806967";"38";"Patent Bioactivity Data";"";"";"None";""
"CHEMBL4857583";"";"0";"468.59";"0";"2.36";"C5";"Cc1nc(Nc2ncc(C(=O)Nc3c(C)cncc3C)s2)cc(N2CCN(CCO)CC2)n1";"IC50";"'='";"340.0";"nM";"6.47";"";"";"UO_0000065";"13.80";"0.27";"4.11";"5.42";"0";"CHEMBL4807589";"Inhibition of SIK3 (unknown origin) using RBER-CHKtide as substrate in presence of [32P]gammaATP by microplate scintillation counter analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4806967";"38";"Patent Bioactivity Data";"";"";"None";""
"CHEMBL507361";"MIRDAMETINIB";"2";"482.20";"0";"2.47";"PD-325901";"O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL3545215";"BMS-911543";"2";"432.53";"0";"3.50";"BMS-911543";"CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL3182621";"AZD-8330";"1";"461.23";"0";"1.83";"AZD-8330";"Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL2364611";"GALUNISERTIB";"2";"369.43";"0";"3.51";"Galunisertib";"Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL608533";"MIDOSTAURIN";"4";"570.65";"2";"5.91";"Midostaurin";"CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL2107832";"PIMASERTIB";"2";"431.21";"0";"1.65";"Pimasertib";"O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL283120";"AXL-1717";"2";"414.41";"0";"2.41";"AXL-1717";"COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL1336";"SORAFENIB";"4";"464.83";"1";"5.55";"Sorafenib";"CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL4092508";"";"0";"658.56";"2";"5.74";"2t";"COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl";"Activity";"'='";"100.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4044163";"Inhibition of wild-type human partial length QSK (A90 to L395 residues) expressed in HEK293 cells assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043093";"1";"Scientific Literature";"Eur J Med Chem";"2017";"CHEMBL3307715";""
"CHEMBL4580220";"BAY-3827";"0";"468.54";"1";"5.45";"EUB0000311";"CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12";"% Control";"";"74.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507319";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL4096145";"";"0";"377.49";"0";"3.42";"2";"CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N";"Activity";"'='";"68.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4054983";"Inhibition of wild-type human partial length QSK (A90 to L395 residues) expressed in mammalian expression system assessed as residual activity at 50 nM by Kinomescan method relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052645";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL4521594";"BAY-1797";"0";"416.89";"0";"3.96";"EUB0000309";"NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1";"% Control";"";"87.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507265";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL4436748";"SR-318";"0";"459.59";"0";"4.47";"EUB0000132";"Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1";"% Control";"";"94.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507315";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 100.0 nM"
"CHEMBL4548361";"";"0";"484.09";"1";"5.19";"6";"COc1cc(Br)cc2[nH]c(I)c(-c3cnc(-c4ccc[nH]4)o3)c12";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4338192";"Inhibition of SIK3 (unknown origin) by [33P]-ATP filter binding kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4334516";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL4088216";"TP-030-1";"0";"402.45";"0";"2.35";"EUB0000719";"CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21";"IC50";"";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4884858";"QSK(SIK3LGP1) Takeda global kinase panel";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507327";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1.0 µM"
"CHEMBL4228713";"A-1211212";"0";"896.51";"3";"9.44";"EUB0000263";"CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1";"% Control";"";"89.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507310";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL4865345";"";"0";"533.46";"1";"2.82";"C3";"Cc1nc(Nc2ncc(C(=O)Nc3c(Br)ccnc3C)s2)cc(N2CCN(CCO)CC2)n1";"IC50";"'='";"2780.0";"nM";"5.56";"";"";"UO_0000065";"10.41";"0.23";"2.74";"4.65";"0";"CHEMBL4807589";"Inhibition of SIK3 (unknown origin) using RBER-CHKtide as substrate in presence of [32P]gammaATP by microplate scintillation counter analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4806967";"38";"Patent Bioactivity Data";"";"";"None";""
"CHEMBL4869199";"";"0";"489.01";"0";"2.71";"C4";"Cc1nc(Nc2ncc(C(=O)Nc3c(C)cncc3Cl)s2)cc(N2CCN(CCO)CC2)n1";"IC50";"'='";"677.0";"nM";"6.17";"";"";"UO_0000065";"12.62";"0.26";"3.46";"5.17";"0";"CHEMBL4807589";"Inhibition of SIK3 (unknown origin) using RBER-CHKtide as substrate in presence of [32P]gammaATP by microplate scintillation counter analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4806967";"38";"Patent Bioactivity Data";"";"";"None";""
"CHEMBL4872654";"";"0";"454.56";"0";"2.06";"C6";"Cc1nc(Nc2ncc(C(=O)Nc3cccnc3C)s2)cc(N2CCN(CCO)CC2)n1";"IC50";"'='";"987.0";"nM";"6.01";"";"";"UO_0000065";"13.21";"0.26";"3.95";"5.03";"0";"CHEMBL4807589";"Inhibition of SIK3 (unknown origin) using RBER-CHKtide as substrate in presence of [32P]gammaATP by microplate scintillation counter analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4806967";"38";"Patent Bioactivity Data";"";"";"None";""
"CHEMBL4867844";"";"0";"494.05";"0";"3.38";"C7";"Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1";"IC50";"'='";"52.3";"nM";"7.28";"";"";"UO_0000065";"14.74";"0.31";"3.90";"6.84";"0";"CHEMBL4807589";"Inhibition of SIK3 (unknown origin) using RBER-CHKtide as substrate in presence of [32P]gammaATP by microplate scintillation counter analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4806967";"38";"Patent Bioactivity Data";"";"";"None";""
"CHEMBL4855726";"";"0";"504.02";"2";"2.53";"B3";"Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1";"IC50";"'='";"250.0";"nM";"6.60";"";"";"UO_0000065";"13.10";"0.27";"4.07";"5.02";"0";"CHEMBL4807589";"Inhibition of SIK3 (unknown origin) using RBER-CHKtide as substrate in presence of [32P]gammaATP by microplate scintillation counter analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4806967";"38";"Patent Bioactivity Data";"";"";"None";""
"CHEMBL4847716";"";"0";"494.05";"0";"3.38";"D1";"Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)csc3C)s2)cc(N2CCN(CCO)CC2)n1";"IC50";"'='";"40.0";"nM";"7.40";"";"";"UO_0000065";"14.97";"0.32";"4.02";"6.95";"0";"CHEMBL4807589";"Inhibition of SIK3 (unknown origin) using RBER-CHKtide as substrate in presence of [32P]gammaATP by microplate scintillation counter analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4806967";"38";"Patent Bioactivity Data";"";"";"None";""
"CHEMBL4859969";"";"0";"514.46";"1";"3.72";"D7";"Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"15.21";"0.33";"4.10";"7.35";"0";"CHEMBL4807589";"Inhibition of SIK3 (unknown origin) using RBER-CHKtide as substrate in presence of [32P]gammaATP by microplate scintillation counter analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4806967";"38";"Patent Bioactivity Data";"";"";"None";""
"CHEMBL4875238";"";"0";"464.02";"0";"4.01";"D9";"Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(C)CC2)n1";"IC50";"'='";"60.0";"nM";"7.22";"";"";"UO_0000065";"15.56";"0.33";"3.21";"8.37";"0";"CHEMBL4807589";"Inhibition of SIK3 (unknown origin) using RBER-CHKtide as substrate in presence of [32P]gammaATP by microplate scintillation counter analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4806967";"38";"Patent Bioactivity Data";"";"";"None";""
"CHEMBL4516471";"BI 1675";"0";"554.64";"1";"2.95";"BI 1675";"O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1";"% Control";"";"95.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507284";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL4520788";"BAY-294";"0";"448.59";"1";"5.58";"EUB0000743";"CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1";"% Control";"";"78.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507273";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL496102";"AMG-208";"2";"383.41";"0";"3.93";"AMG-208";"COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL3188267";"CAPMATINIB";"4";"412.43";"0";"3.43";"Capmatinib";"CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL3989868";"TUCATINIB";"4";"480.53";"1";"5.09";"ARRY-380";"Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL3426621";"RIPASUDIL";"2";"323.39";"0";"1.75";"Ripasudil";"C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL3582478";"MSD-CYP11B2";"0";"311.36";"0";"3.80";"EUB0000313";"CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1";"% Control";"";"97.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507294";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL1289926";"AXITINIB";"4";"386.48";"0";"4.64";"8";"CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL31965";"CANERTINIB";"3";"485.95";"0";"4.39";"Canertinib";"C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL3348923";"MLN-2480";"1";"506.30";"1";"3.98";"MLN-2480";"C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL1614766";"RO-4987655";"1";"565.29";"1";"3.16";"Ro-4987655";"O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL554";"LAPATINIB";"4";"581.07";"2";"6.14";"Lapatinib";"CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL521851";"PICTILISIB";"2";"513.65";"1";"2.15";"Pictilisib";"CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL3544960";"AT-13148";"1";"313.79";"0";"2.92";"AT-13148";"NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL1234354";"PF-04691502";"2";"425.49";"0";"2.25";"PF-04691502";"COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL4206831";"";"0";"535.61";"2";"5.49";"2; FMF-03-145-1";"CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1";"Activity";"'='";"100.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4186021";"Binding affinity to wild-type human partial length QSK (A90 to L395 residues) expressed in HEK293 cells at 1 uM by Kinomescan method relative to control";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4184148";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL4591082";"SR-302";"0";"622.79";"1";"3.26";"EUB0000712";"CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1";"% Control";"";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507324";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 100.0 nM"
"CHEMBL1738757";"REBASTINIB";"2";"553.60";"2";"6.05";"Rebastinib";"CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL3186534";"RIVOCERANIB";"3";"397.48";"0";"4.68";"Apatinib";"N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL3128043";"PF-03758309";"1";"490.64";"0";"4.53";"PF-3758309";"Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL3218576";"COPANLISIB";"4";"480.53";"1";"0.66";"Copanlisib";"COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL4282264";"A-485";"0";"536.48";"1";"3.68";"EUB0000328";"CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O";"% Control";"";"94.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507259";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL4077123";"";"0";"647.78";"2";"6.25";"9; CHMFL-BTK-01";"C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1";"Activity";"'='";"78.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4025352";"Inhibition of wild-type human partial length QSK (A90 to L395 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024706";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";""
"CHEMBL3545396";"BMS-690514";"2";"368.44";"0";"1.38";"BMS-690514";"COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL475251";"R-406";"2";"470.46";"0";"3.63";"R-406";"COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL4445670";"BAY-885";"0";"515.54";"1";"3.28";"EUB0000250";"CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1";"% Control";"";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507268";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL3582461";"MSD-CYP11B2-Negative-control";"0";"303.29";"0";"4.45";"EUB0000733";"FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1";"% Control";"";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507294";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL4075278";"";"0";"417.85";"0";"4.43";"EUB0000316";"O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1";"% Control";"";"75.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507304";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL4516611";"BTZO-1";"0";"240.29";"0";"2.72";"EUB0000301";"O=c1nc(-c2ccccn2)sc2ccccc12";"% Control";"";"85.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507329";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL4630641";"A-769";"0";"339.47";"0";"3.00";"EUB0000332";"CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1";"% Control";"";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507260";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL4580220";"BAY-3827";"0";"468.54";"1";"5.45";"EUB0000311";"CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12";"% residual kinase activity";"";"84.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4884484";"SIK3(h) Eurofins kinase panel";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507319";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1.0 µM"
"CHEMBL4531220";"BI 3047";"0";"515.53";"1";"3.80";"EUB0000586";"CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1";"% Control";"";"81.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507277";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL4555459";"";"0";"481.60";"1";"5.59";"43";"O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1";"Inhibition";"'='";"88.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4389449";"Inhibition of wild-type human partial length QSK (A90 to L395 residues) expressed in mammalian expression system at 10 uM by Kinomescan method relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4387741";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"None";""
"CHEMBL4549667";"TP-030-2";"0";"481.35";"0";"3.12";"EUB0000720";"CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21";"IC50";"";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4885149";"QSK(SIK3LGP1) Takeda global kinase panel";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507326";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1.0 µM"
"CHEMBL4535474";"BAY-293";"0";"448.59";"1";"5.58";"EUB0000320";"CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1";"% Control";"";"90.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507273";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL4538174";"ERKi";"0";"311.35";"0";"2.33";"EUB0000298";"C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1";"% Control";"";"79.6";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507286";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 100.0 nM"
"CHEMBL4455923";"";"0";"575.63";"2";"4.23";"48c";"CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1";"Inhibition";"'<'";"50.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4405565";"Inhibition of wild-type human partial length QSK (A90 to L395 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4402587";"1";"Scientific Literature";"J Med Chem";"2020";"None";""
"CHEMBL4522773";"BAY-827";"0";"385.86";"0";"4.94";"BAY-827";"CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1";"% Control";"";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507263";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL4551344";"A-1210227";"0";"904.37";"3";"8.88";"EUB0000746";"O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1";"% Control";"";"76.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507310";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL4588900";"BI 1230";"0";"816.98";"3";"6.14";"BI 1230";"COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C";"% Control";"";"97.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507284";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL4539555";"BI 9307";"0";"546.61";"1";"1.77";"EUB0000343";"CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1";"% Control";"";"98.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507278";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL4552354";"BI 3017";"0";"407.43";"0";"1.30";"EUB0001066";"Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1";"% Control";"";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507275";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL2170610";"BI 9627";"0";"356.35";"0";"2.05";"EUB0000295";"CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1";"% Control";"";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507279";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL215152";"AZD-1152-HQPA";"0";"507.57";"1";"3.50";"AZD-1152 HQPA";"CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908471";"Binding constant for QSK kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat. Biotechnol.";"2011";"None";""
"CHEMBL558752";"RAF-265";"2";"518.42";"2";"6.93";"CHIR-265/RAF-265";"Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908471";"Binding constant for QSK kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat. Biotechnol.";"2011";"None";""
"CHEMBL428690";"ALVOCIDIB";"3";"401.85";"0";"3.30";"Flavopiridol";"CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908471";"Binding constant for QSK kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat. Biotechnol.";"2011";"None";""
"CHEMBL91829";"RUBOXISTAURIN";"3";"468.56";"0";"3.51";"LY-333531";"CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908471";"Binding constant for QSK kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat. Biotechnol.";"2011";"None";""
"CHEMBL513909";"BI-2536";"2";"521.67";"1";"3.56";"BI-2536";"CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908471";"Binding constant for QSK kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat. Biotechnol.";"2011";"None";""
"CHEMBL372764";"PERIFOSINE";"3";"461.67";"1";"6.99";"Perifosine";"CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL4475097";"";"0";"437.09";"1";"5.35";"2";"COc1cc(Br)cc2[nH]cc(-c3cnc(-c4ccc(Br)[nH]4)o3)c12";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4338192";"Inhibition of SIK3 (unknown origin) by [33P]-ATP filter binding kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4334516";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL4446434";"";"0";"358.20";"0";"4.59";"4";"COc1cc(Br)cc2[nH]cc(-c3cnc(-c4ccc[nH]4)o3)c12";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4338192";"Inhibition of SIK3 (unknown origin) by [33P]-ATP filter binding kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4334516";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL1939876";"BI 4394";"0";"446.46";"0";"3.37";"EUB0000730";"CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1";"% Control";"";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507281";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 100.0 nM"
"CHEMBL3907057";"BAY-826";"0";"558.54";"2";"7.59";"EUB0000713";"Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1";"% Control";"";"75.3";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507270";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 100.0 nM"
"CHEMBL4630644";"BAY-386";"0";"514.53";"1";"3.27";"EUB0000291";"O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1";"% Control";"";"77.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507269";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL1822792";"MK-2461";"2";"495.56";"0";"2.15";"MK-2461";"CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL4564337";"";"0";"358.20";"0";"4.59";"3";"COc1cc2c(-c3cnc(-c4ccc[nH]4)o3)c[nH]c2cc1Br";"IC50";"'='";"1200.0";"nM";"5.92";"";"";"UO_0000065";"16.53";"0.37";"1.33";"8.86";"0";"CHEMBL4338192";"Inhibition of SIK3 (unknown origin) by [33P]-ATP filter binding kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4334516";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL3991932";"PEXMETINIB";"1";"556.64";"2";"6.07";"Pexmetinib";"Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL3545076";"LY-2584702";"1";"445.42";"0";"4.30";"LY-2584702";"Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL1879463";"DACTOLISIB";"3";"469.55";"1";"5.89";"Dactolisib";"Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL1230607";"PHA-793887";"1";"361.49";"0";"2.31";"PHA-793887";"CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL4465866";"";"0";"901.82";"None";"None";"8a";"CO[C@@H]1[C@H](NCCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4";"Kd";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"8.87";"None";"None";"None";"0";"CHEMBL4322746";"Binding affinity to recombinant N-terminal His-FLAG-GST-tagged SIK3 (unknown origin) (59 to 365 residues) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321812";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308860";""
"CHEMBL4563315";"";"0";"325.85";"0";"3.97";"29";"CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N";"Activity";"'='";"100.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4333604";"Binding affinity to wild-type human partial length QSK (A90 to L395 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4330132";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"None";""
"CHEMBL4564312";"BAY-786";"0";"672.12";"2";"5.26";"EUB0000335";"O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1";"% Control";"";"72.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507266";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL502835";"NINTEDANIB";"4";"539.64";"1";"3.62";"Nintedanib";"COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL522892";"DOVITINIB";"3";"392.44";"0";"2.54";"Dovitinib";"CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL551064";"AEW-541";"1";"425.54";"0";"4.67";"AEW-541";"Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL3544966";"GSK-1059615";"1";"333.37";"0";"3.62";"GSK-1059615";"O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL2133806";"JNJ-38877605";"1";"377.36";"0";"3.21";"JNJ-38877605";"Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL4584981";"NVS-MALT1-C";"0";"574.03";"1";"4.72";"EUB0000747";"CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12";"% Control";"";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507320";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL4458424";"BAY-899";"0";"459.46";"1";"5.12";"EUB0000240";"O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1";"% Control";"";"86.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507317";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL296468";"BMS-387032";"1";"380.54";"0";"3.66";"BMS-387032";"CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL1201182";"TEMSIROLIMUS";"4";"1030.30";"None";"None";"3";"CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL495727";"AT-9283";"2";"381.44";"0";"2.07";"AT-9283";"O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1";"Kd";"'='";"4108.0";"nM";"5.39";"";"Active";"UO_0000065";"14.12";"0.26";"3.32";"4.85";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";"r = 0.84 None"
"CHEMBL1091644";"LINSITINIB";"3";"421.50";"0";"4.82";"Linsitinib";"C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL3188551";"GSK-2636771";"2";"433.43";"0";"4.26";"GSK-2636771";"Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL1800285";"MSD-M1PAM";"0";"388.43";"0";"2.45";"EUB0000252";"N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1";"% Control";"";"97.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507295";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL4082756";"TP-024";"0";"392.36";"0";"3.73";"EUB0000317";"Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O";"% Control";"";"83.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507305";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL4534005";"GSM-NC";"0";"496.49";"0";"4.53";"EUB0000739";"COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1";"% Control";"";"92.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507289";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL3417525";"BI 665915";"0";"458.53";"0";"2.78";"EUB0000749";"CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1";"% Control";"";"70.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507276";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL3799512";"TP-004";"0";"363.34";"0";"2.92";"EUB0000303";"Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12";"% Control";"";"53.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507303";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL388978";"STAUROSPORINE";"0";"466.54";"0";"4.35";"Staurosporine";"CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4";"IC50";"'='";"0.972";"nM";"9.01";"";"";"UO_0000065";"19.32";"0.35";"4.66";"12.98";"0";"CHEMBL4720554";"Inhibition of human SIK3 using AMARAASAAALARRR as substrate by [gamma-33P]-ATP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715818";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL4794578";"";"0";"397.44";"0";"2.58";"7";"CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12";"Activity";"'='";"106.27";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4721604";"Inhibition of SIK3 (unknown origin) assessed as residual activity at 1 uM by Kinomescan method relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715821";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"Dose = 1.0 microM"
"CHEMBL4165749";"BI 2545";"0";"527.43";"1";"4.24";"EUB0000318";"O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1";"% Control";"";"79.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507275";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL4247298";"";"0";"586.70";"2";"5.44";"15i";"Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1";"Activity";"'='";"96.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4230921";"Binding affinity to wild-type human partial length QSK (A90 to L395 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229344";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";""
"CHEMBL3628627";"";"0";"684.77";"3";"5.33";"4";"CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1";"Inhibition";"'='";"99.61";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3631472";"Inhibition of SIK3 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3627608";"1";"Scientific Literature";"Bioorg. Med. Chem.";"2015";"None";""
"CHEMBL3545154";"POZIOTINIB";"2";"491.35";"1";"5.38";"Poziotinib";"C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL2103839";"RIDAFOROLIMUS";"3";"990.22";"3";"7.74";"Deforolimus";"CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL2110732";"DACOMITINIB";"4";"469.95";"1";"5.16";"Dacomitinib";"COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL535";"SUNITINIB";"4";"398.48";"0";"3.33";"Sunitinib";"CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL206834";"BAFETINIB";"2";"576.63";"2";"5.39";"Bafetinib";"Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL1090090";"VX-702";"2";"404.32";"0";"3.62";"VX-702";"NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL124660";"TANDUTINIB";"2";"562.72";"2";"5.03";"Tandutinib";"COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL1171837";"PONATINIB";"4";"532.57";"1";"4.46";"Ponatinib";"Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL2079588";"TELATINIB";"2";"409.83";"0";"3.95";"Telatinib";"CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL300138";"ENZASTAURIN";"3";"515.62";"1";"4.93";"Enzastaurin";"Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL1615025";"TAK-733";"1";"504.23";"1";"1.07";"TAK-733";"Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL3590106";"ULIXERTINIB";"2";"433.34";"0";"4.67";"Ulixertinib";"CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL3402762";"TEPOTINIB";"4";"492.58";"0";"4.01";"Tepotinib";"CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL2103840";"DINACICLIB";"3";"396.50";"0";"2.28";"Dinaciclib";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL3991933";"";"0";"308.35";"0";"3.11";"Sapanisertib";"Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL3039513";"DECERNOTINIB";"2";"392.39";"0";"3.28";"Decernotinib";"CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL3301610";"ABEMACICLIB";"4";"506.61";"1";"4.94";"Abemaciclib";"CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL574737";"UCN-01";"2";"482.54";"0";"3.84";"UCN-01";"CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O";"Kd";"'='";"56.0";"nM";"7.25";"";"Active";"UO_0000065";"15.03";"0.28";"3.41";"8.09";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";"r = 0.93 None"
"CHEMBL2180604";"TAK-593";"1";"445.48";"0";"3.47";"TAK-593";"Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL3545157";"TIDEGLUSIB";"2";"334.40";"0";"3.26";"Tideglusib";"O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL1976040";"ADAVOSERTIB";"2";"500.61";"1";"2.89";"MK-1775";"C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL2028663";"DABRAFENIB";"4";"519.57";"2";"5.36";"Dabrafenib";"CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1";"Kd";"'='";"2005.0";"nM";"5.70";"";"Active";"UO_0000065";"10.97";"0.22";"0.34";"5.14";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";"r = 0.99 None"
"CHEMBL1614713";"CC-401";"2";"388.48";"0";"3.88";"CC-401";"c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL1231124";"AZD-1480";"2";"348.77";"0";"3.01";"AZD-1480";"Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL2216870";"IDELALISIB";"4";"415.43";"0";"3.75";"Idelalisib";"CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL3991931";"";"0";"456.51";"0";"3.31";"ONO-4059-analogue";"C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL483158";"ALISERTIB";"3";"518.93";"2";"5.75";"Alisertib";"COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL462018";"TRICIRIBINE PHOSPHATE";"2";"400.29";"1";"-1.77";"Triciribine";"CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL4448899";"BAY-876";"0";"496.42";"0";"4.17";"EUB0000307";"Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1";"% Control";"";"81.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507267";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL4066040";"A-1596584";"0";"539.53";"2";"5.45";"EUB0000264";"COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1";"% Control";"";"95.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507262";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL4093612";"A-1596586";"0";"539.53";"2";"5.45";"EUB0000544";"COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1";"% Control";"";"82.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507262";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL1651534";"PF-04457845";"2";"455.44";"1";"5.39";"EUB0000306";"O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1";"% Control";"";"83.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507297";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL4857318";"";"0";"419.90";"0";"3.00";"C11";"Cc1nc(NCCO)cc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)n1";"IC50";"'='";"1510.0";"nM";"5.82";"";"";"UO_0000065";"13.86";"0.28";"2.82";"4.66";"0";"CHEMBL4807589";"Inhibition of SIK3 (unknown origin) using RBER-CHKtide as substrate in presence of [32P]gammaATP by microplate scintillation counter analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4806967";"38";"Patent Bioactivity Data";"";"";"None";""
"CHEMBL4574669";"";"0";"395.46";"0";"1.93";"(R,R)-36n";"CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1";"Inhibition";"";"";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4352063";"Inhibition of human SIK3 (1 to 307 residues) using KKKVSRSGLYRSPSMPENLNRPR as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4350961";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL4438024";"";"0";"265.19";"0";"0.29";"7a; NSC30049; NSC49L";"ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]";"Activity";"'='";"101.42";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4327877";"Inhibition of human SIK3 assessed as residual activity at 1 uM using AMARAASAAALARRR as substrate by [gamma-33P]-ATP assay relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4325871";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";""
"CHEMBL4522930";"BI-605906";"0";"432.52";"0";"2.49";"None";"CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12";"% Ctrl";"";"79.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4887320";"SIK3 Invitrogen Lab (UK) kinase screen (BI)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Assay technology: LanthaScreen | Assay type: biochemical | Mode of action: inhibitor | Target type: Kinase";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4800722";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1.0 µM"
"CHEMBL4568183";"SR-301";"0";"673.84";"1";"3.82";"EUB0001060";"CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1";"% Control";"";"78.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507324";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 100.0 nM"
"CHEMBL1800685";"PPTN";"0";"475.51";"1";"7.36";"EUB0000274";"O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1";"% Control";"";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507292";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL4455582";"BAY-693";"0";"529.57";"1";"3.59";"EUB0000708";"Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1";"% Control";"";"91.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507268";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL3685796";"MRL-SYKi";"0";"452.58";"1";"5.06";"EUB0000714";"Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1";"% Control";"";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507285";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 100.0 nM"
"CHEMBL4867844";"";"0";"494.05";"0";"3.38";"C7";"Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1";"Activity";"'<'";"25.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4808003";"Inhibition of SIK3 (unknown origin) assessed as residual activity measured at 1 uM";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4806967";"38";"Patent Bioactivity Data";"";"";"None";"Dose = 1.0 microM"
"CHEMBL1236962";"OMIPALISIB";"1";"505.51";"1";"4.84";"Omipalisib";"COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL3137331";"DEFACTINIB";"2";"510.50";"1";"2.40";"Defactinib";"CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL3120215";"OSI-027";"2";"406.45";"0";"3.22";"OSI-027";"COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL400402";"";"0";"475.98";"1";"5.58";"TG-100572";"Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12";"Kd";"'='";"3.0";"nM";"8.52";"";"Active";"UO_0000065";"17.91";"0.34";"2.94";"10.22";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";"r = 0.92 None"
"CHEMBL38380";"FASUDIL";"3";"291.38";"0";"1.22";"Fasudil";"O=S(=O)(c1cccc2cnccc12)N1CCCNCC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL1946170";"REGORAFENIB";"4";"482.82";"1";"5.69";"Regorafenib";"CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL494089";"GSK-690693";"1";"425.49";"0";"1.58";"GSK-690693";"CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL405130";"WHI-P131";"1";"297.31";"0";"3.10";"JANEX-1";"COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL3544983";"TESEVATINIB";"3";"491.39";"1";"5.79";"Tesevatinib";"COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL4577237";"BI 9446";"0";"602.48";"2";"5.77";"EUB0000549";"C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21";"% Control";"";"98.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507282";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL4100408";"TP-024n";"0";"377.39";"0";"4.22";"EUB0000336";"Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1";"% Control";"";"75.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507305";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL3342332";"A-1155463";"0";"669.80";"2";"6.33";"EUB0000262";"CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1";"% Control";"";"77.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507311";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL3589752";"IPP/CNRS-A017";"0";"403.40";"1";"5.45";"EUB0000276";"Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F";"% Control";"";"98.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507312";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL4456123";"BI 639667";"1";"451.48";"0";"2.78";"EUB0000352";"CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1";"% Control";"";"81.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507278";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL204232";"NAPHTHYRIDINONE";"0";"514.80";"2";"6.39";"EUB0000296";"CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12";"% Control";"";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507287";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL4546802";"BAY-4900";"0";"437.24";"1";"5.07";"EUB0000709";"Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21";"% Control";"";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507274";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 100.0 nM"
"CHEMBL4851745";"";"0";"458.98";"0";"3.35";"C10";"Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(N2CCN(C)CC2)n1";"IC50";"'='";"493.0";"nM";"6.31";"";"";"UO_0000065";"13.74";"0.28";"2.96";"6.36";"0";"CHEMBL4807589";"Inhibition of SIK3 (unknown origin) using RBER-CHKtide as substrate in presence of [32P]gammaATP by microplate scintillation counter analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4806967";"38";"Patent Bioactivity Data";"";"";"None";""
"CHEMBL4865214";"";"0";"454.56";"0";"2.06";"C2";"Cc1nc(Nc2ncc(C(=O)Nc3ncccc3C)s2)cc(N2CCN(CCO)CC2)n1";"IC50";"'='";"1100.0";"nM";"5.96";"";"";"UO_0000065";"13.11";"0.25";"3.90";"4.99";"0";"CHEMBL4807589";"Inhibition of SIK3 (unknown origin) using RBER-CHKtide as substrate in presence of [32P]gammaATP by microplate scintillation counter analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4806967";"38";"Patent Bioactivity Data";"";"";"None";""
"CHEMBL4850733";"";"0";"458.55";"1";"1.96";"C9";"Cc1nc(Nc2ncc(C(=O)Nc3c(C)noc3C)s2)cc(N2CCN(CCO)CC2)n1";"IC50";"'='";"800.0";"nM";"6.10";"";"";"UO_0000065";"13.30";"0.26";"4.14";"4.60";"0";"CHEMBL4807589";"Inhibition of SIK3 (unknown origin) using RBER-CHKtide as substrate in presence of [32P]gammaATP by microplate scintillation counter analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4806967";"38";"Patent Bioactivity Data";"";"";"None";""
"CHEMBL4865466";"";"0";"492.03";"0";"3.93";"D8";"CC(=O)N1CCN(c2cc(Nc3ncc(C(=O)Nc4c(C)csc4Cl)s3)nc(C)n2)CC1";"IC50";"'='";"150.0";"nM";"6.82";"";"";"UO_0000065";"13.87";"0.29";"2.89";"6.60";"0";"CHEMBL4807589";"Inhibition of SIK3 (unknown origin) using RBER-CHKtide as substrate in presence of [32P]gammaATP by microplate scintillation counter analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4806967";"38";"Patent Bioactivity Data";"";"";"None";""
"CHEMBL1645462";"AC-480";"1";"530.56";"1";"3.86";"AC-480";"Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL270995";"BRIVANIB ALANINATE";"3";"441.46";"0";"3.42";"Brivanib_alaninate";"Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL4513786";"A-545";"0";"532.72";"2";"5.54";"EUB0000289";"CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC";"% Control";"";"74.8";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507258";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL1939880";"BI 4395";"0";"374.40";"0";"3.20";"EUB0000727";"Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1";"% Control";"";"94.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507281";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 100.0 nM"
"CHEMBL1643772";"CRTH2-negative-control";"0";"494.57";"0";"2.45";"EUB0000334";"CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1";"% Control";"";"89.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507290";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL3628628";"";"0";"453.93";"0";"3.77";"5";"COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC";"Inhibition";"'='";"6.53";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3631472";"Inhibition of SIK3 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3627608";"1";"Scientific Literature";"Bioorg. Med. Chem.";"2015";"None";""
"CHEMBL4592872";"BAY-897";"0";"457.48";"1";"6.33";"EUB0000340";"O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1";"% Control";"";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507317";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL3358954";"BI 653048";"1";"515.53";"1";"3.80";"EUB0000314";"CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1";"% Control";"";"85.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507277";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL1421";"DASATINIB";"4";"488.02";"0";"3.31";"A8";"Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1";"Activity";"'<'";"25.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4808003";"Inhibition of SIK3 (unknown origin) assessed as residual activity measured at 1 uM";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4806967";"38";"Patent Bioactivity Data";"";"";"None";"Dose = 1.0 microM"
"CHEMBL4455357";"TP-020";"0";"654.02";"2";"5.45";"EUB0000315";"Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1";"% Control";"";"94.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507302";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL4585243";"BAY-7598";"0";"505.57";"1";"3.60";"EUB0000728";"O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O";"% Control";"";"61.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507264";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL561132";"MK-7246";"1";"416.47";"0";"3.04";"EUB0000297";"CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1";"% Control";"";"98.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507290";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL4533479";"A-1806262";"0";"558.68";"2";"5.81";"EUB0000339";"CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1";"% Control";"";"89.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507261";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL3609637";"GSM1";"0";"514.48";"1";"4.67";"EUB0000753";"COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1";"% Control";"";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507289";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL440687";"ABT-724";"0";"293.37";"0";"2.28";"EUB0000290";"c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1";"% Control";"";"91.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507260";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL4630643";"BAY-448";"0";"458.46";"0";"2.78";"EUB0000333";"Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1";"% Control";"";"78.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507269";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL4516843";"BAY-207";"0";"477.37";"1";"5.10";"EUB0000548";"NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1";"% Control";"";"87.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507265";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL3701197";"A-226";"0";"221.27";"0";"3.78";"EUB0000547";"CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1";"% Control";"";"89.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507256";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL4528675";"";"0";"535.55";"1";"4.76";"8d-1";"COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1";"Inhibition";"'='";"8.49";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4366590";"Inhibition of human SIK3 at 100 nM using AMARAASAAALARRR as substrate by [gamma-33P]-ATP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4364276";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";""
"CHEMBL4802045";"BAY-091";"0";"440.48";"1";"5.56";"None";"CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O";"Inhibition";"";"5.14";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4888061";"SIK3(h) Millipore kinase panel";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4800729";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1.0 µM"
"CHEMBL3286797";"PF-04418948";"1";"409.41";"0";"3.59";"EUB0000351";"COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1";"% Control";"";"72.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507298";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL4585920";"TP-020n";"0";"520.95";"1";"3.61";"EUB0001079";"Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1";"% Control";"";"83.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507302";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL4568735";"NVS-MALT1";"0";"574.03";"1";"4.72";"EUB0000239";"CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12";"% Control";"";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507320";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL3799292";"(R)-9s";"0";"300.75";"0";"2.20";"EUB0000300";"C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N";"% Control";"";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507301";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL4537788";"BAY-784";"0";"672.12";"2";"5.26";"EUB0000347";"O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1";"% Control";"";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507266";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL3697701";"A-079";"0";"207.25";"0";"3.47";"EUB0000308";"CCC(=N\O)/C(C)=C/c1ccc(F)cc1";"% Control";"";"68.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507256";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL4750196";"";"0";"598.99";"2";"5.57";"6g";"O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F";"Activity";"'='";"98.6";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4720897";"Inhibition of human SIK3 assessed as residual activity using AMARAASAAALARRR as substrate at 1 uM by [gamma-33P]-ATP assay relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715818";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"Dose = 1.0 microM"
"CHEMBL2336325";"VISTUSERTIB";"2";"462.55";"0";"2.50";"AZD-2014";"CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL482767";"SNS-314";"1";"430.95";"0";"4.52";"SNS-314";"O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL3991929";"Cerdulatinib Hydrochloride";"0";"482.01";"0";"1.37";"Cerdulatinib Hydrochloride";"CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl";"Kd";"'='";"13559.0";"nM";"4.87";"";"Active";"UO_0000065";"10.93";"0.21";"3.50";"3.64";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";"r = 0.85 None"
"CHEMBL572881";"MOTESANIB";"3";"373.46";"0";"4.04";"Motesanib";"CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991880";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: yes";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster lab chemical proteomics drug profiling";"Science";"2017";"None";""
"CHEMBL4445335";"";"0";"595.65";"2";"7.07";"Roxyl-ZV-5J";"Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1";"Inhibition";"'='";"43.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4408134";"Inhibition of recombinant human SIK3 (1 to 307 residues) at 1 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4406821";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";""
"CHEMBL4559936";"";"0";"613.73";"2";"6.20";"(+/-)-6";"O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O";"Activity";"'='";"23.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4391552";"Binding affinity to wild-type human partial length QSK (A90 to L395 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4390652";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";""
"CHEMBL4516982";"BI 1935";"0";"498.47";"0";"3.80";"None";"CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O";"% Control";"";"92.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507283";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL4552180";"BAY-588";"0";"527.52";"2";"5.59";"EUB0000251";"Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1";"% Control";"";"91.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507267";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL2204283";"MSD-M1PAM-NC";"0";"441.54";"0";"2.99";"EUB0000344";"N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1";"% Control";"";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507295";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL3797887";"(S)-9s";"0";"300.75";"0";"2.20";"EUB0000341";"C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N";"% Control";"";"94.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507301";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL4063249";"TP-021n";"0";"284.71";"0";"3.12";"EUB0000742";"N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1";"% Control";"";"75.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507304";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL4560241";"BI 0153";"0";"430.47";"0";"2.14";"EUB0000740";"CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1";"% Control";"";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507276";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL2204538";"THPP-1";"0";"464.91";"0";"3.06";"EUB0000751";"COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2";"% Control";"";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507293";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 100.0 nM"
"CHEMBL4780458";"";"0";"457.42";"0";"4.04";"EUB0000540";"O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1";"% Control";"";"74.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507297";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL4566600";"PPTN-NC";"0";"489.54";"1";"7.67";"EUB0000337";"Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12";"% Control";"";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507292";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL4540759";"BI 0054";"0";"382.39";"0";"2.12";"EUB0000545";"CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1";"% Control";"";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507279";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL4531775";"SR-321";"0";"512.58";"2";"5.91";"EUB0000711";"O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1";"% Control";"";"76.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507315";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 100.0 nM"
"CHEMBL4859689";"";"0";"471.59";"1";"1.70";"C8";"Cc1nc(Nc2ncc(C(=O)Nc3c(C)nn(C)c3C)s2)cc(N2CCN(CCO)CC2)n1";"IC50";"'='";"9730.0";"nM";"5.01";"";"";"UO_0000065";"10.63";"0.21";"3.31";"4.03";"0";"CHEMBL4807589";"Inhibition of SIK3 (unknown origin) using RBER-CHKtide as substrate in presence of [32P]gammaATP by microplate scintillation counter analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4806967";"38";"Patent Bioactivity Data";"";"";"None";""
"CHEMBL4518706";"PF-00911705";"0";"508.49";"1";"2.53";"EUB0000702";"CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O";"% Control";"";"82.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507299";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL4793380";"";"0";"423.48";"0";"4.34";"17d";"CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1";"Activity";"'='";"96.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4766938";"Inhibition of recombinant human SIK3 (1 to 307 residues) assessed as residual activity at 10 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765237";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"Dose = 10.0 microM | TIME = 0.6667 hr"
"CHEMBL4856384";"";"0";"487.63";"1";"0.75";"C12";"Cc1nc(Nc2ncc(C(=O)NC3CN4CCC3CC4)s2)cc(NN2CCN(CCO)CC2)n1";"IC50";"'='";"8850.0";"nM";"5.05";"";"";"UO_0000065";"10.36";"0.20";"4.30";"4.15";"0";"CHEMBL4807589";"Inhibition of SIK3 (unknown origin) using RBER-CHKtide as substrate in presence of [32P]gammaATP by microplate scintillation counter analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4806967";"38";"Patent Bioactivity Data";"";"";"None";""
"CHEMBL3617968";"BAY-678";"0";"400.36";"0";"4.11";"EUB0000735";"CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1";"% Control";"";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507272";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL4561806";"BTZO-4";"0";"242.30";"0";"2.62";"EUB0001135";"O=C1NC(c2ccccn2)Sc2ccccc21";"% Control";"";"70.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507329";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL4530740";"BI 1950";"0";"646.51";"2";"5.16";"EUB0000310";"C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1";"% Control";"";"76.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507282";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL4098877";"MLi-2";"0";"379.46";"0";"3.56";"EUB0000715";"C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1";"% Control";"";"74.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507291";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 100.0 nM"
"CHEMBL1834184";"BI 99179";"0";"391.47";"0";"4.15";"EUB0000294";"CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1";"% Control";"";"84.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507280";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL1091513";"MRK-560";"0";"517.93";"1";"4.67";"EUB0000750";"O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F";"% Control";"";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507288";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL4526351";"BAY-309";"0";"519.50";"2";"7.41";"EUB0000703";"Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1";"% Control";"";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507270";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL4560589";"MLi-2-NC";"0";"393.49";"0";"3.58";"EUB0000706";"C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1";"% Control";"";"63.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507291";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL4537673";"BAY-985";"0";"553.59";"1";"4.38";"EUB0000305";"C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1";"% Control";"";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507318";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 100.0 nM"
"CHEMBL111612";"ABT-546";"0";"532.72";"2";"5.54";"EUB0000348";"CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC";"% Control";"";"60.5";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507258";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL332794";"A-192621";"0";"558.68";"2";"5.81";"EUB0000350";"CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1";"% Control";"";"71.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507261";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL4630642";"BAY-974";"0";"422.49";"0";"4.42";"EUB0000707";"CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1";"% Control";"";"81.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507319";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1000.0 nM"
"CHEMBL4518342";"THPP-1-NC";"0";"493.45";"1";"5.47";"EUB0000744";"CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1";"% Control";"";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4879925";"KinomeScan assay: inhibition of QSK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: A90/L395 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL6149";"Serine/threonine-protein kinase SIK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507293";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 100.0 nM"
